NCT01701505View on ClinicalTrials.gov

Dose-Ranging Study of Intranasal Kovacaine Mist in Pediatric Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Anesthesia
Interventions
DRUG

400uL of Kovacaine Mist

2 unilateral intranasal sprays of 200uL each.

DRUG

200uL of Kovacaine Mist

2 unilateral intranasal sprays of 100uL each.

DRUG

120uL of Kovacaine Mist

2 unilateral intranasal sprays of 60uL each.

Trial Locations (1)

80525

Big Grins, Fort Collins

All Listed Sponsors
collaborator

Triligent International

INDUSTRY

collaborator

Rho, Inc.

INDUSTRY

lead

St. Renatus, LLC

INDUSTRY

NCT01701505 - Dose-Ranging Study of Intranasal Kovacaine Mist in Pediatric Subjects | Biotech Hunter | Biotech Hunter